Description
OFXIN-OZ contains Ofloxacin 200 mg + Ornidazole 500 mg Tablets, a combination of antibacterial and antiprotozoal medicines used for selected infections caused by susceptible microorganisms. Ofloxacin works against susceptible bacteria, while Ornidazole acts against certain anaerobic bacteria and protozoa.
In addition, this combination may be prescribed for certain gastrointestinal and other infections when both bacterial and protozoal organisms are suspected. Therefore, OFXIN-OZ should be used only according to the diagnosis and prescription of a qualified healthcare professional.For other tablet formulations, you can also explore the MedHexa Pharma Tablet Products range.
Therapeutic Segment
Anti-Infective | Antibacterial | Antiprotozoal | Gastrointestinal
Uses of OFXIN-OZ
OFXIN-OZ may be prescribed for selected infections caused by susceptible bacteria or protozoa.
It may be used for:
- Infectious diarrhea
- Dysentery
- Certain gastrointestinal infections
- Mixed bacterial and protozoal infections
- Other susceptible infections as diagnosed by a healthcare professional
However, the exact indication depends on the cause and severity of the infection. Therefore, do not use this medicine without appropriate medical advice.
Key Benefits of Using OFXIN-OZ
OFXIN-OZ combines two anti-infective medicines that work against different types of susceptible microorganisms.
- Contains Ofloxacin 200 mg
- Contains Ornidazole 500 mg
- Provides antibacterial activity against susceptible bacteria
- Provides antiprotozoal activity against susceptible protozoa
- May help manage selected gastrointestinal infections
- May be prescribed for certain cases of infectious diarrhea and dysentery
- Convenient oral tablet formulation
- Supplied in 10 × 10 blister packaging
Furthermore, the two ingredients have different mechanisms of action. As a result, the combination may provide antimicrobial coverage when both susceptible bacterial and protozoal organisms contribute to an infection.
How the Combination Works
Ofloxacin belongs to the fluoroquinolone group of antibiotics. It interferes with bacterial enzymes involved in DNA replication and repair. Consequently, susceptible bacteria cannot multiply normally and may die.
Meanwhile, Ornidazole belongs to the nitroimidazole group of anti-infective medicines. It acts against susceptible anaerobic microorganisms and protozoa by damaging their DNA.
Therefore, the combination can act against susceptible bacteria and protozoa involved in selected infections.
Side Effects of OverUsing OFXIN-OZ
Some patients may experience side effects while taking this combination.
Possible effects include:
- Nausea
- Vomiting
- Abdominal discomfort
- Diarrhea
- Headache
- Dizziness
- Loss of appetite
- Metallic taste
These effects may not occur in everyone. However, contact your healthcare professional if symptoms become severe, persistent or unusual.
Seek medical attention if you develop difficulty breathing, facial swelling, severe allergic symptoms, significant tendon pain or swelling, or severe neurological symptoms.
Safety Information for OFXIN-OZ
Use OFXIN-OZ only according to your healthcare professional’s prescription.
Before starting treatment, tell your doctor if you:
- Have an allergy to Ofloxacin, other quinolone antibiotics, Ornidazole or related medicines
- Have kidney or liver problems
- Have a history of tendon disorders
- Have seizures or other neurological conditions
- Have heart rhythm problems
- Are pregnant, planning pregnancy or breastfeeding
- Take prescription medicines, over-the-counter medicines or supplements
In addition, tell your doctor about all medicines and mineral supplements you take because Ofloxacin can interact with certain medicines and products containing calcium, iron, magnesium or aluminium.
Avoid alcohol during Ornidazole treatment and for the period recommended by your healthcare professional after treatment. Alcohol may increase the risk of unpleasant reactions.
Furthermore, do not use antibiotics for viral infections such as the common cold or flu. Do not stop or change the prescribed course unless your healthcare professional advises you to do so.
For additional information about Ofloxacin, refer to the DailyMed Ofloxacin Drug Information.
Dosage & Administration
Take OFXIN-OZ exactly as prescribed by your healthcare professional.
- Swallow the tablet with water.
- Take the medicine at the prescribed time.
- Follow the recommended dose and treatment duration.
- Do not take more than the prescribed amount.
- Avoid taking Ofloxacin at the same time as antacids or mineral supplements containing aluminium, magnesium, calcium or iron unless your doctor or pharmacist provides specific instructions.
- Avoid alcohol during treatment and for the period advised by your healthcare professional.
- If you miss a dose, take it when you remember unless it is nearly time for your next dose.
- Do not take an extra dose to compensate for a missed dose.
The appropriate dose and treatment duration depend on the type of infection, its severity and the patient’s individual health factors. Therefore, always follow your doctor’s prescription.
Ofloxacin 200 mg & Ornidazole 500 mg Information
OFXIN-OZ combines Ofloxacin 200 mg and Ornidazole 500 mg in an oral tablet formulation.
Ofloxacin provides antibacterial activity against susceptible bacteria. Meanwhile, Ornidazole acts against susceptible anaerobic bacteria and protozoa. Therefore, healthcare professionals may prescribe the combination for selected infections where these microorganisms are involved.
The product is supplied in 10 × 10 blister packaging.
Storage
- Store OFXIN-OZ according to the conditions stated on the product label.
- Keep the tablets in their original packaging.
- Protect the medicine from excessive heat and moisture.
- Keep away from direct sunlight.
- Store in a cool and dry place.
- Keep out of reach of children.
- Do not use the medicine after the expiry date.
- Do not use the tablets if the packaging is damaged.
- Follow any additional storage instructions printed on the product packaging.






Reviews
There are no reviews yet.